Please login to the form below

Not currently logged in
Email:
Password:

MHRA and Swissmedic pledge greater collaboration

Product safety regulators to share information and promote international cooperation
From left: Swissmedic's Jürg Schnetzer and MHRA's Dr Ian Hudson

From left: Swissmedic's Jürg Schnetzer and MHRA's Dr Ian Hudson

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) and its Swiss counterpart Swissmedic have pledged to improve international collaboration in addressing product safety concerns.

The two regulatory agencies signed a memorandum of understanding at the Summit of the Heads of Medicines Regulatory Agencies, hosted by Swissmedic in Interlaken, Switzerland earlier this week.

Agreeing to support each other's regulatory frameworks, requirements and processes as well as share information - the topic of this year's summit - the two bodies look to lead the way in creating a more collaborative approach to international public health.

As part of the deal, the MHRA and Swissmedic will unite in combatting safety challenges in medicines, medical devices, and components for transfusion, such as the globalisation of therapeutic products research and production, and the increasing complexity of scientific and technological developments.

MHRA chief executive Dr Ian Hudson, commented: “Part of our commitment to protecting the health of UK citizens is by creating close ties with international counterparts.

“Through closer collaboration, we can provide a basis for increasing shared initiatives as well as create a foundation for easier information-sharing.

“We operate in a global environment and agreements such as these serve to further strengthen our ability to promote good practices and we look forward to working even closer with our Swiss counterparts.”

Article by
Rebecca Clifford

12th October 2016

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics